Search Results 151-160 of 41717 for Two-phase
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
A Phase 2/3 Study On The Efficacy And Safety Of Mangaciclanol For ContrastEnhanced MRI Of CNS Or Body In Adult Patients · Overview · Participation eligibility.
A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated ...
Expansion phase to evaluate safety, efficacy and pharmacokinetics of NEOD001 in 25 additional subjects at the maximum tolerated dose. Participation eligibility.
The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...
About this study. The purpose of trhis study is to evaluate CPI-0610 in patients who have both received JAK inhibitors, such as ruxolitinib (Arms 1 and 2), ...
End-stage kidney disease may need to be treated with mechanical filtering of the kidneys, called dialysis, or a kidney transplant. Eye damage. Diabetes ...
To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). Like BPD/DS , the SADI-S procedure also has two steps, with the first step being a ...
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA · Overview · Participation eligibility · Participating Mayo Clinic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!